Amarna secures $11M for SV40 gene therapy platform Oct. 17, 2019 By Cormac Sheridan No Comments DUBLIN – Amarna Therapeutics BV raised €10 million (US$11.1 million) in new financing to move its SV40-based gene therapy platform, SVac, toward the clinic.Read More